BCX-17725
- Generic Name
- BCX-17725
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- BioCryst Pharmaceuticals
- Target Recruit Count
- 72
- Registration Number
- NCT06539507
- Locations
- 🇦🇺
Investigative site, Brisbane, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath